Diagnosis and treatment of von Willebrand disease in 2024 and beyond - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Haemophilia Année : 2024

Diagnosis and treatment of von Willebrand disease in 2024 and beyond

Résumé

Abstract Manuscript Background and Aim The diagnosis and clinical care of patients with von Willebrand disease (VWD) has continued to evolve since the characterization of the von Willebrand factor (VWF) gene in 1985. This condition is almost certainly the most common inherited bleeding disorder, and the major symptomatic burden of the disease is experienced by females during their reproductive years. Diagnosis relies on the identification of a personal and family history of excessive mucocutaneous bleeding, and laboratory features consistent with quantitative and/or qualitative abnormalities of VWF. This review focuses on three aspects of VWD management, with current updates and a look into the future. Manuscript Themes First, we will address the role of genetics in the diagnosis and possible therapies for VWD. With current technologies, VWD genetic diagnosis is usually confined to the confirmation of type 2 subtypes of the disease and type 3 VWD analysis for family planning. While type 3 VWD is a potential candidate for the application of gene therapy, no treatments are currently close to entering the clinic. Second, the peri‐procedural management of patients with VWD remains an important element of care. The choice of product, its dose and schedule all require careful consideration depending upon the type and disruptive nature of the planned procedure. Lastly, in addition to gene therapy, several other novel therapeutic interventions are also being developed for bleeding and prophylaxis in VWD. These include a VWF aptamer interfering with VWF clearance and bioengineered forms of VWF.
Fichier non déposé

Dates et versions

hal-04505836 , version 1 (15-03-2024)

Identifiants

Citer

Paula James, Frank Leebeek, Caterina Casari, David Lillicrap. Diagnosis and treatment of von Willebrand disease in 2024 and beyond. Haemophilia, 2024, ⟨10.1111/hae.14970⟩. ⟨hal-04505836⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More